Monica Gandhi MD, MPH is an Infectious Diseases doctor, Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the Director of the UCSF Center for AIDS Research (CFAR) and the Medical Director of the HIV Clinic (“Ward 86”) at San Francisco General Hospital. Her research focuses on HIV and women and adherence measurement in HIV treatment and prevention and most recently, on how to mitigate the COVID-19 pandemic.
Shabir Madhi M.B.B.C.H. (Wits), FCPaeds(SA), Ph.D is the Dean of the Faculty of Health Sciences and Professor of Vaccinology at the University of the Witwatersrand, Johannesburg, South Africa. He also holds the position of Director of the South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit (VIDA) and is co-Director of the African Leadership Initiative for Vaccinology Expertise (ALIVE). He has in the past led studies on pneumococcal conjugate vaccine and rotavirus vaccine in Africa, which informed WHO recommendations on the use of these vaccines in low and middle income settings. He has led studies on the clinical development of vaccines for pregnant women aimed at protection of mother-infant dyads. Most recently he led the first two COVID-19 vaccine studies being undertaken in Africa, and has been involved in multiple epidemiological studies on Covid-19 in South Africa. He has co-authored more than 480 scientific manuscripts since 1997, mainly on vaccine preventable diseases.
Linda-Gail Bekker is the Director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town and Chief Research Officer of the Desmond Tutu Health Foundation. She is a physician scientist and infectious disease specialist. Her research interests include programmatic and action research around antiretroviral roll out and TB integration, prevention of HIV in women, youth and MSM. Prof Bekker has also recently been involved in a number of COVID19 vaccine trials and co-leads the Sisonke Phase 3B study which has seen the vaccination of 500 000 health care workers in South Africa. She has led numerous investigator-driven studies in HIV treatment, prevention and tuberculosis. She is a past president of the International AIDS Society and served as the International Co-Chair of the 9th IAS Conference and 22nd International AIDS Conference and Co-Chaired the Research 4 Prevention Conference that was held in January 2021.
Dennis Burton is the Chair and Professor in the Department of Immunology & Microbiology and holds the James & Jessie Minor Chair in Immunology. He received his B.A. in Chemistry from Oxford University and his Ph.D from Lund University, Sweden in physical biochemistry. He is the Scientific Director of the IAVI Neutralizing Antibody Center, Director of The Consortium for HIV/AIDS Vaccine Development (CHAVD) at Scripps Research, and a member of the Ragon Institute of MGH, MIT and Harvard, Boston, USA. He has held many research grants from the NIH and has published more than 450 papers in scientific journals. He has received numerous awards including the Jenner Fellowship of the Lister Institute and a Fellowship in the American Academy of Microbiology. His research is focused on infectious disease, in particular the interplay of antibodies and highly mutable viruses, notably HIV. He is interested in the potential of broadly neutralizing antibodies to inform vaccine design.
Mandisa Dukashe is a clinician with more than 15 years’ experience leading HIV programs (across the cascade), a community systems strengthening consultant and an AVAC 2020 Fellow. She has been openly living with HIV for more than 18 years and working closely with UN Agencies translating the Global Aids Strategies into local context. She is a pioneer of Undetectable and Untransmittable (U=U) South Africa Movement and a co-founder of U=U Africa Coalition (a campaign that seeks to place PLWHIV at the centre of the HIV prevention and treatment agenda across the region). She advocates for WLWHIV rights and client centred care, locally and regionally.
Francois Venter MD, FCP, PhD is the Divisional Head of Ezintsha at the University of the Witwatersrand, Johannesburg, where he received most of his training. He has an active interest in public sector access to HIV services, and his work involves health systems and other research that directly translates into national public health programmes, most recently involving dolutegravir. He leads multiple antiretroviral treatment optimisation studies, and is currently working on new first and second line antiretroviral options, patient linkage-to-care interventions, and self-testing projects. He has led large PEPFAR-funded HIV programmes in South Africa, focusing on different populations such as men, women, children, young people, truckers, sex workers and LGBTI. For the last 20 years, he has been an advisor to bodies such as the South African government, Southern African HIV Clinicians Society, UNAIDS and WHO, including contributing to international, regional and national HIV guidelines. He has been involved in several human rights cases involving HIV within the Southern African region, and has an active interest in medical ethics.
Mark Sonderup graduated MBChB from the University of Cape Town in 1995. Following his internship training, his postgraduate training was at the University of Cape Town and Groote Schuur Hospital where he obtained a Fellowship of the College of Physicians in 2002. Between 2002 and 2004, he completed a 2-year fellowship in Hepatology at the UCT/Medical Research Council Liver Research Centre and Liver Clinic at Groote Schuur Hospital, Cape Town. He worked in the UK before being appointed as a Senior Specialist in the Department of Medicine and Division of Hepatology at UCT and Groote Schuur Hospital in 2007. He was granted a FRCP (London) in 2018. He is currently Associate Professor in the Department of Medicine and Division of Hepatology. Research interest include viral hepatitis and drug induced liver injuries. He has assisted in co-authoring the national viral hepatitis guidelines and elimination strategy for South Africa. He currently serves on the WHO Strategic Advisory Committee on Viral Hepatitis and is a Board Member of the African Hepatitis Initiative.
Nelesh Govender was co-chair of the SAHCS cryptococcal disease guideline committee in 2013 and 2019. He is a Centre Head at the National Institute for Communicable Diseases, a Professor in the School of Pathology at Wits University and an Honorary Professor at the University of Cape Town and University of Exeter.
Nicholas Paton trained in medicine and infectious diseases at Cambridge University, Sydney and London and in epidemiology at the London School of Hygiene and Tropical Medicine. He is a Professor of Infectious Diseases at the National University of Singapore and London School of Hygiene and Tropical Medicine. His research interests are in HIV and TB, in particular conducting clinical trials of novel interventions for these diseases. He has been the Chief Investigator for several investigator-initiated second-line HIV clinical trials designed to be relevant to the WHO public health approach including the EARNEST trial that enrolled over 1200 patients at 14 sites in 5 sub-Saharan African countries; and the ongoing NADIA trial conducted in Uganda, Kenya and Zimbabwe. He also leads a programme of TB clinical trials based in Singapore including the TRUNCATE-TB trial, investigating a novel treatment strategy approach for TB with 2-month treatment regimens.
José Arribas is currently the head of the Infectious Diseases Unit and Research Director of HIV and Infectious Diseases at La Paz Hospital, and associate professor of Medicine at the Autonoma University School of Medicine all in Madrid, Spain. Dr. Arribas received his medical degree from the Complutense University School of Medicine, Madrid. Following this, he completed his residency in Internal Medicine at La Paz Hospital before going on to pursue a fellowship in Infectious Diseases at Washington University, St. Louis, Missouri, USA. During his fellowship, he performed clinical research at the Washington University AIDS Clinical Trials Unit.
His research interests, which include antiretroviral therapy, development of new antiretrovirals and emerging infectious diseases have driven the publication of more than 340 scientific papers many of them clinical trials or antiretroviral therapy. Dr. Arribas is a member of the GESIDA (Spanish Group for the study of AIDS) antiretroviral therapy expert guidelines and chair of the antiretroviral panel of the European AIDS Clinical Society (EACS) guidelines. He is a member of the editorial committee of Antiviral Therapy, HIV Medicine, Open Forum in Infectious Diseases and Lancet HIV
Roy Gulick is Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine, and Attending Physician at the New York Presbyterian Hospital in New York City. He is board certified in internal medicine and infectious diseases.
Dr. Gulick’s research interests include designing, conducting and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess antiretroviral agents with new mechanisms of action. He currently serves as Principal Investigator of the Cornell-New Jersey HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG) and the HIV Prevention Trials Network (HPTN), sponsored by the U.S. National Institutes of Health.
He also serves as the Co-Chair of the U.S. Department of Health and Human Services (DHHS) Panel on Clinical Practices for Treatment of HIV Infection, a Board Member of the International Antiviral Society-USA, and previously served as a Member and as Chair of the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) and as a Member and as Chair of the NIH Office of AIDS Research Advisory Committee (OARAC). He most recently serves as the Co-Chair of the NIH COVID-19 Treatment Guidelines Panel. He is a Member of the American Society of Clinical Investigation, the Association of American Physicians, International AIDS Society, and the Infectious Diseases Society of America, and has presented at national and international meetings and published widely.
Graeme Meintjes is the Second Chair and Deputy Head of Medicine at the University of Cape Town, and also holds the DST/NRF SARChI Chair of Poverty-related Diseases. He leads a research programme that focuses on the clinical conditions affecting patients with advanced HIV disease including disseminated HIV-associated tuberculosis and cryptococcal meningitis. His group also investigates drug-resistant tuberculosis and diagnostics for TB. He has been the PI or local PI of several clinical trials and conducts observational cohort studies that address questions related to disease pathogenesis. He has contributed to the development of management guidelines for HIV, TB and cryptococcal meningitis at a provincial and national level and in WHO Guideline Development Groups. He undertakes clinical work as a Specialist at Groote Schuur Hospital and Khayelitsha Hospital in Cape Town.
Andrew Hill graduated from Oxford University, and then studied at St Mary’s Hospital in London before getting his PhD from the University of Amsterdam. He has worked on the development of treatments for HIV since the early 1990s. He is currently a Senior Visiting Research Fellow at the University of Liverpool, specialising in treatment access issues.
Yunus Moosa is an Associate Professor, Chief Specialist and Head of the Department of Infectious Diseases at the University of KwaZulu-Natal. His work focuses on the care of inpatients and outpatients with complex infectious disease issues. He is involved in bedside teaching and training of medical students, postgraduates at all levels and Infectious Diseases Subspecialists. His research interests include HIV drug resistance, diagnosis of smear negative tuberculosis and TB drug induced liver injury. He is the current President and Chair of the Board of Directors of the Southern African HIV Clinicians Society (SAHCS).
Natasha Davies, Medical degree (Glasgow, 2002), HIV Management Diploma (South Africa, 2006), Master of Public Health degree (Liverpool, 2011), has been an HIV clinician since 2004, supporting the South African ART programme across different contexts. She now works at Anova Health Institute where she enjoys a healthy balance of clinical work and public health/programmatic support work. Her key focus areas are PMTCT, advanced clinical care including virological failure and treatment optimisation, and male engagement within maternal and child health spaces. She is also part of several NDoH working groups seeking to improve access to optimal ART and PrEP, particularly for pregnant and breastfeeding women. Much of her clinical time is spent providing care to high risk PMTCT clients, pregnant and breastfeeding women with unsuppressed viral loads and/or advanced clinical care needs.
Glenda Gray is the first female President and CEO of the South African Medical Research Council (SAMRC). She was the Chair of the Research Committee on COVID-19, bringing together scientific evidence and experience to the Minister of Health and the National Coronavirus Command Council. Gray spearheads the SAMRC funding broadly and for COVID-19.
In her first five-year tenure at the helm of the SAMRC, the organisation experienced five consecutive clean audits, transformed grant funding initiatives that significantly improved funding for young scientists, black African scientists and women; and established key collaborations and partnerships that will significantly progress scientific research.
Gray studied medicine and paediatrics at Wits University where she remains a Full Professor: Research in the School of Clinical Medicine. A National Research Foundation A1-rated scientist, Gray is world-renowned for her research in HIV vaccines and interventions to prevent mother to child transmission of HIV. She co-founded and led, with James McIntyre, the globally eminent Perinatal HIV Research Unit at Chris Hani Baragwanath Hospital in Soweto. For this work, she and McIntyre received the Nelson Mandela Health and Human Rights Award in 2002.
She is co-Principal Investigator of the National Institutes of Health-funded HIV Vaccine Trials Network (HVTN) and directs the programme in Africa. Amongst many others, Gray’s accolades include the Hero of Medicine Award from the International Association of Physicians in AIDS Care, and the Outstanding Africa Scientist Award from the European and Developing Countries Clinical Trials Partnership.
Forbes named Gray one of Africa’s 50 Most Powerful Women and TIME as one of the world’s 100 Most Influential people. In 2013, she was awarded South Africa’s highest honour, the Order of Mapungubwe. Her qualifications include MBBCh (Wits), FCPaeds (SA), DSc (honoris causa Simon Fraser University), DSc (honoris causa Stellenbosch University), and LLD (honoris causa Rhodes University)
Helen Rees is Founder and Executive Director of Wits RHI at the University of Witwatersrand in Johannesburg, South Africa. She is a Personal Professor in the University of Witwatersrand’s Department of Obstetrics and Gynaecology and the Co-Director of ALIVE (African Leadership in Vaccinology Expertise) which is Wits University’s flagship vaccinology programme. She is an Honorary Professor in the Department of Clinical Research at the London School of Hygiene and Tropical Medicine (LSHTM).
Prof Rees has extensive experience in the field of medicines regulation and Chairs the South African Health Products Regulatory Authority (SAHPRA). She has been very involved in national, regional and global response efforts to COVID-19 including the development of COVID-19 vaccines, their potential rollout and utilization. In South Africa, Prof Rees is a member of the Ministerial Advisory Committee on COVID-19, a member of the Ministerial Advisory Committee on COVID-19 vaccines and Chairs the VACC-MAC COVID-19 Variant Technical Working Group. Internationally, she is a member of the COVAX committee on COVID-19 maternal immunization, a member of WHO’s expert committee on COVID-19 vaccines and a member of WHO’s Scientific and Technical Advisory Group on Infectious Hazards. GAVI, CEPI and WHO are jointly driving the global COVID vaccine effort including the COVAX facility, and Prof Rees is involved with the oversight of the COVAX facility. She is a member of the WHO IHR Emergency Committee on COVID-19. Prof Rees has worked extensively with WHO and other institutions in the African region and Chairs the WHO’s African Regional Immunisation Technical Advisory Group on Immunization (RITAG). Prof Rees is widely recognised for her work as a global health practitioner and has been appointed as chair and member of many international scientific committees and Boards. She is currently the chair of WHO’s International Health Regulation (IHR) Polio Emergency Committee and Co-Chair of the WHO SAGE Working Group on Ebola Vaccines. Prof Rees is a member of the Global Alliance for Vaccines and Immunization (Gavi) Board and chairs the Gavi Programme and Policy Committee. She is a member of the Coalition for Epidemic Preparedness and Innovation (CEPI) Board and chairs the CEPI Scientific Advisory Committee.
Prof Rees has been recognised with many awards for her contribution to medicine, global health, human rights and women’s rights. She was awarded the South African Order of the Baobab and was made an Officer of the British Empire (OBE) by Queen Elizabeth II.
Ndiviwe Mphothulo holds an MB CHB, a Diploma in HIV management (SA), a Master of Public Health (MPH) , a Master of Business Leadership (MBL), and is currently a PHD candidate (Public Health). He has been a Board member of the Southern African HIV Clinicians Society since 2016. He is also an Executive committee member of Rural Doctors Association of Southern Africa (RuDASA), where holds the position of Treasurer. He has been a medical doctor for 19 years and has extensive experience in HIV management at both the private and public sector. Dr Mphothulo has also worked at Taung District Hospital’s TB unit for 14 years and MDR-TB unit for 9 years. At Taung District Hospital he was part of the first wellness clinic rolling out ARVs in 2004, and led establishing of the Decentralised MDR-TB unit in 2009 which serves the whole Dr. Ruth Segomotsi Mompati District. In recognition of efforts in combating challenges in rural health, and the South African health system Dr Mphothulo has received the following accolades: 2013 Service Excellence Award from the Health MEC, for best performing Doctors in North West Province; 2014 Community Medical Builder Award from the South African Medical Association Trade Union, 2015 South African Rural Doctor of the Year from RuDASA, 2017 Best performing MDR-TB doctor in North West Province from Chief Director (HAST), and the Spirit of Medicine Award, 2018, from the South African Medical Association (SAMA), The Certificate of appreciation from RuDASA for working under adversity in 2019, and the Annual award from the South African Public Health Association (PHASA), and was appointed to the Ministerial Advisory Committee on Covid-19 (MAC) in March 2020.
Dave Spencer is a South African Infectious Diseases clinician and currently assists the Southern African Clinicians’ Society as the Editor-in-Chief of the Southern African Journal of HIV Medicine. He was born in South Africa in 1950 and completed undergraduate training in medicine at the University of Cape Town, 1969-1974. He later trained in Internal Medicine and Oncology at the University of the Witwatersrand, Johannesburg, and from 1988-1990, trained in Infectious Diseases with Emanuel Wolinsky at Case Western Reserve University in Cleveland, USA. Over the 45 years that Dr Spencer has practiced medicine in South Africa has worked in rural hospitals, Mseleni Hospital, KwaZulu Natal, in private practice in Johannesburg, and in recent years returned to the academic world of Wits University and several NGOs active in the care of those living with HIV. In 2004 he published ‘The Clinical Practice of HIV Medicine. A practical guide to the care of the HIV infected’, one of the first of its kind on the African continent. Dr Spencer has published in the field of HIV medicine and has been principal investigator of many early studies in antiretroviral treatment. He was a founding member of the SAHCS and on its executive for the first decade of its existence. Dr Spencer regards the greatest gift of medicine to be that of the care of the sick and the alleviation of human suffering.
Andrew Scheibe is a medical doctor by training who works in harm reduction research, programmes and policy in South Africa and the region. His work focuses on the intersections between infectious diseases, determinants of health and rights. He is a technical advisor for TB HIV Care and is a researcher at the University of Pretoria’s Department of Family Medicine.
Nigel Garrett, MBBS MRCP MSc, PhD is a Specialist Physician in HIV and Sexual Health from the UK, and Head of the HIV Pathogenesis and Vaccine Research programme at CAPRISA. He is the Investigator of Record for the HIV Vaccine Trials Network (HVTN) and COVID-19 Prevention Network (CoVPN) studies at CAPRISA and has conducted HIV prevention research in South Africa for the past 10 years. He has a special interest in point-of-care technology to improve care pathways and treatment outcomes for patients with STIs and HIV.
Ian Proudfoot is a family physician, who after over twenty years working in a large general practice in Cape Town, narrowed down his focus to HIV and TB medicine in 2008, taking up a clinical position working a semi-rural NGO in Mpumalanga. After a few years gaining experience in this setting and completing the Diploma in HIV management, he moved back to Cape Town to join Médecins Sans Frontières /Doctors Without Borders (MSF) in their HIV/TB project in Khayelitsha for a few years before taking up a full-time teaching post for another Cape Town-based division of MSF. Before the pandemic struck, this involved teaching HIV and TB to clinicians in a variety of rural settings in MSF projects spread across Africa and South East Asia. Now involved in a variety of online teaching and learning initiatives, he is also nearing the end of a masters course in health professions education at Stellenbosch University, a learning journey that has augmented his passion for the development of workplace-based education initiatives for primary care clinicians in rural communities.
Silingene Ngcobo is an aspiring nurse academic from the University of KwaZulu-Natal, who started her nursing career in 1999 and since 2007 has diverted her interest more towards nurse training programmes at various levels, with special interest on HIV and AIDS training for nurses. Silingene is a current PhD candidate with North West University, holds a Masters’ degree in Nursing from University of KwaZulu-Natal, Post-Graduate Diploma in Clinical Management of HIV/AIDS from University of KwaZulu-Natal, Diploma in Primary Health Care from University of KwaZulu-Natal, Honors’ Degree in Health Sciences from University of South Africa, Bachelor of Nursing Degree with specialization in Nursing Education and Nursing Administration from University of South Africa, Diploma in Nursing (General, Community, Psychiatry) and Midwifery from KwaZulu-Natal College of Nursing. She is the current member of Honor Society of Nursing, Sigma Cheta Tau International, and International Collaboration Community Health Nursing Research (ICCHNR) and has published research articles. Registered with South African Nursing Council and is currently involved in HIV inter-professional education project.
Tim Tucker is founder and CEO of the public health organization, SEAD Consulting. In addition, he is an adjunct professor at the University of Cape Town School of Public Health and Family Medicine. Tim is a public health strategist, with a track record in HIV, hepatitis, vaccines, COVID and public health programs in Africa and beyond. He is a registered Clinical Virologist. He has obtained his medical degree, his Ph.D. and pathology specialization at UCT.
Tim worked as a clinical virologist, before being the inaugural director of the South African AIDS Vaccine initiative, the (then) largest biotech and clinical initiative on the continent. He founded his Black-empowered consultancy 17 years ago, and SEAD has consulted to companies, foundations, governments, donors, NGO’s, universities, research organizations, unions, etc on health strategy and health program interventions.
Tim leads SEAD – a major recipient of donor grants for improvement of health systems, and has staff in every province of South Africa. SEAD has >120 staff, who focus on health systems strengthening, particularly within the context of HTS quality improvement, laboratory strengthening, clinic strengthening, pharmacy service support, and has a significant business analytics/M&E offering.
In the last 18 months of COVID, SEAD has pivoted much of the HIV-related services to also support the national COVID efforts. In addition, SEAD has produced all the COVID protocols, guidelines, and webinars for the entire “Post School Education and Training (PSET) Sector – universities, TVET Colleges and Community Colleges.
Tim has served on multiple healthcare organization boards over the years, and is currently a member of the SA Medical Research Council Board, NHLS Research Trust Board, SHAWCO Board; and is a member of the US Government National Institutes of Health HIV Strategy Working Group, the most senior structure in this US Government research institution advising on HIV funding and priorities. He served as a member of the National Health Laboratory Service Board for 7 years until December 2019.
Julia Turner, MBChB (UCT), Diploma in HIV Management (CMSA), completing MPH (UWC), completing Postgraduate diploma in Health Science Education (Wits). Julia is medical doctor in the role of Senior Technical Adviser for HIV Care and Treatment for Right to Care NGO, based in South Africa. She is on the SA National Third Line ARV Committee, a number of National Technical Working Groups and is a reviewer for the Southern African Journal of HIV Medicine. She is passionate about training healthcare workers and has provided training on HIV resistance, new ARVs and strategies to improve adherence, throughout South Africa and in many other African countries. Her areas of interest include health care worker education, paediatric and adult HIV management, HIV resistance, psychosocial aspects of HIV management including adolescent disclosure and adherence, and programmatic aspects of HIV control.
Lisa Horak is a paediatrician running the paediatric HIV clinic at Dora Nginza Hospital, Gceberha. She qualified in Zimbabwe (MBChB), and did her post-graduate paediatric qualification (MRCPCH) in the UK, as well as a Diploma in Tropical Medicine and Hygiene (DTMH). Dr Horak worked in the UK for 11 years and also briefly in Nepal. She has been working in paediatric HIV in South Africa for 6 years.
Samanta Lalla-Edward is a public health monitoring and evaluation (M&E) specialist with over 15 years of experience in HIV prevention and treatment research and implementation. She has led the M&E of large PEPFAR programmes in South Africa, including providing technical and training support to all levels of the Department of Health. More recently she has been involved in large donor funded research projects in the areas of HIV prevention technologies, non-communicable diseases and HIV, digital health, medical technologies, and high risk populations. Samanta is passionate about building research capacity particularly for postgraduate students. She collaborates with other investigators in Africa and globally to plan and operationalize clinical and healthcare research, as well as develop local staff in research and scientific writing capability. She is committed to ensuring that young researchers receive the best possible training and support, both, to continue to advance healthcare service delivery and in our fight against HIV and non-communicable diseases.
Louise Kuhn is Professor of Epidemiology at Columbia University Irving Medical Center, New York City. The focus of her research is on helping to support development and implementation of interventions to ameliorate the adverse effects of the HIV pandemic on the lives of children and their families. Recent studies have addressed improving early infant diagnosis programs, facilitating rapid access to antiretroviral treatment for neonates with HIV and investigating immunological and virological factors that could be leveraged to potentially lead to HIV remission or functional cure in infants.
Mohammed Majam is the Head of Medical Technologies at Ezintsha, a division of the Wits Health Consortium. He has been one of the leading role-players in HIV Self-Testing both in South Africa, and Globally. He headed the STAR Project in South Africa between 2017 and 2020 which was responsible for the scale up of HIVSS in the country. He is co-lead author of the SA HIV Clinicians Society HIV Self-Testing guidelines, and member of the National Department of Healths HIVSS Technical Working Group. Mohammed is a leading advocate for self-care, and his current portfolio includes Hepatitis C Self-Testing, as well as COVID-19 Self-Testing.
Leon Levin MBBCh (Wits), FCPaed(SA), DTM&H is a paediatrician who has been treating HIV infected infants, children and adolescents for the past 22 years. From 2013-2018 he was Head of Paediatric HIV Programmes and is currently Senior Technical Advisor in Paediatrics at Right to Care NGO. He was the Chairman of the Paediatric Subcommittee of the SA HIV Clinicians Society from 1999-2011 and was the convenor of the Southern African HIV Clinicians Society Paediatric Antiretroviral Guidelines 2000, 2002 and 2005 and Co-convenor for the 2009 guidelines. He has been on the SA DOH Paediatric and Adolescent ART Guidelines Committees and is on the Paediatric 3rd line ART Committee for the SA DOH. He founded and runs the South African HIV Clinicians Society Paediatric Discussion Group which is an Internet based forum for clinicians to discuss and learn about problems in paediatric patients with HIV. He has given numerous lectures and HIV viral resistance workshops throughout Africa. His Current areas of interest include infants, children and adolescents with HIV infection, treatment failure and drug resistance and HIV disclosure to adolescents.
Carole Wallis is the Medical Director and the Head of the Specialty Molecular Division for BARC-SA and Lancet Laboratories, respectively. She has worked in the field of HIV drug resistance for over ten years and has experience in managing high through-put Molecular Laboratories. Through her work she has been involved in several studies involving the World Health Organization; and studies funded by the NIH, AIDS Fond; and pharmaceutical groups. She has
been involved in multiple studies looking at the development of drug resistance patterns in Sub-Saharan Africa, Eastern and Western Africa covering all major subtypes in those regions (HIV-1 subtype C, D, A and AG); the impact these mutations will have on newer antiretroviral compounds and the use of different diagnostic assays to detect these mutations.
Doug Richman received his AB from Dartmouth College and his MD at Stanford University, where he completed his residency in medicine. He also received an honorary Doctorate in Medicine from the University of Lausanne. He was a Research Associate in the Laboratory of Infectious Diseases at the NIH’s National Institute of Allergy and Infectious Diseases and Clinical Fellow in the Division of Infectious Diseases, at both the Beth Israel Hospital and Children’s Hospital Medical Center of Harvard. He trained as both an infectious disease physician and medical virologist at Stanford, the NIH, and Harvard before joining the faculty at the University of California San Diego (UC San Diego) in 1976.
Dr. Richman’s research focused on influenza virus, herpesviruses and hemorrhagic fever viruses before concentrating on HIV in the early 1980s. He participated in the development of most of the first antiretroviral drugs. He helped design and conduct the clinical evaluation of new drugs and treatment strategies, including the first trial of combination antiretroviral therapy and the initial study documenting the value of the strategy of rendering HIV RNA undetectable. HIV drug resistance was originally recognized in his laboratory in 1988. In addition to his continuing interest in HIV treatment and drug resistance, his research interests have focused on HIV pathogenesis, including the issues of viral latency and evolution. He is currently Distinguished Professor of Pathology and Medicine (Active Emeritus), Florence Seeley Riford Emeritus Chair in AIDS Research, Director of the HIV Institute and Co-Director of the San Diego Center for AIDS Research.
Gayle Sherman is a Professor in the Department of Paediatrics and Child Health, University of the Witwatersrand and Senior Pathologist in the Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa. Qualified as a clinical Paediatric Haematologist she has worked in Prevention of Mother to Child Transmission and Early Infant Diagnosis of HIV programs in research, program implementation and advocacy for the past 20 years. Her current focus is on utilizing the National Health Laboratory Service data warehouse for cost effective, near real-time surveillance of HIV programs.
Henry Sunpath MBBS, Dip HIV Med, MPH, MFam Med is a specialist family physician and began treating PLWH since 1995 in the public health sector while working as an internal medicine registrar. In 2002 he joined Mc Cord hospital and was head of department of medicine and consultant and researcher in the HIV program. His research publications (2004 -2021) include HIV and coinfections, health systems strengthening and HIV VL and Drug Resistance surveillance.
Dr Sunpath has been the PI and coinvestigator of several NIH funded research projects from 2014 -2021.
As co –chair and director of the Annual Workshop in Advanced Clinical Care (AWACC) –AIDS (2006 -2019) , he was involved in continuous medical education in partnership with the KZN health department and UKZN .Currently he holds an honorary clinical fellow post in the Infectious diseases department at Nelson Mandela School and is completing PhD studies in Medicine.
Ewelina Mamcarz is a pediatric hematologist-oncologist in Memphis, Tennessee and is affiliated with the Department of Bone Marrow Transplantation and Cellular Therapy at St. Jude Children’s Research Hospital. She received her medical degree from Medical University of Silesia (Slaska Akademia Medyczna), in Poland and completed her residency at Marshfield Clinic-Saint Joseph’s Children’s Hospital in Wisconsin. Her hematology-oncology fellowship was undertaken at the Children’s National Medical Center, in Washington, DC and at the National Institutes of Health, Hematology Branch, in Maryland, followed by bone marrow transplant fellowship at St. Jude Children’s Research Hospital, in Tennessee. Doctor Mamcarz’s research and clinical interests include transplantation for patients with non-malignant diseases, with a focus on developing prospective transplant protocols for the treatment of SCID and gene therapy for X-linked SCID.
Lucas Hermans is a medical officer at the Division of Infectious Diseases and HIV Medicine at Groote Schuur Hospital/University of Cape Town. He is a PhD student in the group of Annemarie Wensing and Monique Nijhuis at the University Medical Center Utrecht (Utrecht, The Netherlands). The main topic of his PhD project is monitoring of antiretroviral treatment in resource-limited settings.
Sinead Delany-Moretlwe, MBBCh PhD DTM&H is a Professor and Director: Research at Wits RHI at the University of the Witwatersrand, Johannesburg. A South African-born medical doctor, her research has focused on the intersections between sexual and reproductive health (SRH) and HIV, especially in adolescents. She has worked on several phase III trials of new HIV prevention technologies, including PrEP and is currently protocol chair of a phase III trial of injectable cabotegravir for HIV prevention in women affiliated to the HIV Prevention Trials Network (HPTN 084). A key thread of all her research has been successfully taking HIV and sexual and reproductive health interventions to scale within the South African and African context. She is an advisor to the South African National Department of Health PrEP technical working group, and serves on several WHO and other advisory committees. She is national co-PI of the CROWN Coronation trial – a platform trial to evaluate pre-exposure prophylaxis interventions to prevent and mitigate COVID19 in health care workers.
Jacob Estes, Ph.D., is a professor at the VGTI-Vaccine and Gene Therapy Institute and Chief of the Division of Pathobiology & Immunology, at the Oregon National Primate Research Center. Prof Estes is an immunology researcher who studies animal models to better understand how infectious pathogens interact with the humans they infect and cause disease. In particular, he uses nonhuman primate models to evaluate treatments and vaccines against infectious diseases, especially HIV and TB. He has led OHSU’s contributions to two recent scientific papers about the novel coronavirus. The first paper, published May 20 in Science, found nonhuman primates infected with the coronavirus produce neutralizing antibodies, which can help fight off a future infection. The second paper was published Sept. 3 in Nature Medicine and showed a COVID-19 vaccine candidate can prevent severe disease in hamsters, which marked the first time a potential vaccine was shown to protect against severe disease. Estes holds a Ph.D. in immunology and HIV pathogenesis from Brigham Young University. Before joining OHSU in 2017, he worked at the Frederick National Laboratory for Cancer Research’s AIDS and Cancer Virus Program and, prior to that, he was a postdoctoral fellow studying the immunology and pathology of HIV at the University of Minnesota. Dr. Estes is an adjunct professor in the School of Health and Biomedical Sciences in the College of Science, Engineering and Health at RMIT University in Melbourne, Australia, and an honorary professor of immunopathology in the Department of Clinical Medicine at Aarhus University, Denmark.
Tom Boyles is an Infectious Diseases clinician who has most recently worked in both urban and rural settings in South Africa. He is passionate about the appropriate use of medical tests, having written and taught courses to medical students and recently completing a textbook on the subject. He has worked in the field of antibiotic resistance including as an investigator on the MERINO trial and his current research interests include the appropriate diagnosis and treatment of different forms of Tuberculosis in low resource settings.
Richard Lessells is an Infectious Diseases Specialist at the KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP, http://krisp.org.za/), a research centre of the University of KwaZulu-Natal. He is also a Research Associate at the Centre for the Aids Programme of Research in South Africa (CAPRISA, http://www.caprisa.org). He completed his clinical training in the UK but has been based in South Africa since 2007. His clinical work and research is focused on improving clinical care and outcomes for complex HIV and TB disease.
Ahmad Haeri Mazanderani is a clinical virologist based at the Centre for HIV & STIs at the National Institute for Communicable Diseases, Johannesburg. His primary responsibilities are paediatric HIV surveillance.
Katherine Gill is a Clinical Research Site Leader at the Desmond Tutu Health Foundation in Cape Town specializing in HIV Prevention Clinical Trials and COVID research. She has been a medical doctor for 20 years and has 10 years of experience working in HIV/TB clinical management, Grant Management, and clinical research. She is currently completing a degree as master of Public Health.
Prinitha Pillay has worked in the medical field for over 25 years. She has BSc Hons. in Molecular Biology from the University of Witwatersrand and after graduating as a medical doctor, joined Doctors Without Borders (MSF) and worked in many different settings from Lesotho, South and North Sudan, India, Sierra Leone, Libya and in both urban and rural South Africa over 10 years. She served as President of MSF in South Africa and on the Board internationally. She was featured in the Mail and Guardian’s Top 10 Women in Health in 2011. Upon her returned to South Africa she worked as a technical specialist on HIV/TB with RHI, and for the Rural Health Advocacy Project advocating for better access to health for those living in rural areas. She served as an independent panelist on the South African Human Right Commission investigating access to emergency services as a basic human right. During this time, she completed a Master’s degree in Infectious Diseases and Global Policy from the London School of Hygiene and Tropical Medicine. She went on to specialise in Oncology with her Masters in Medicine studying the side effects of patients and sexual function of women with cervical cancer after receiving chemo‐radiation. She continues to advocate for access to state of the art comprehensive cancer care and treatment.
Matthew Chersich is a Research Professor at the University of the Witwatersrand, South Africa and a Visiting Professor at the University of Ghent, Belgium. His career spans more than 20 years working in medical and public health research in Africa, with a focus on maternal health and HIV, and more recently on climate change and health. His university training encompassed both clinical medicine and public health across three high-ranking universities, and at the Colleges of Medicine in South Africa and the United Kingdom. More recently, he spent two years as a visiting student at the Institute of Theology in Assisi, Italy. Overall, he has contributed to 14 WHO guidelines or monologues, with roles spanning guideline writer and reviewer, lead on systematic reviews, lead methodologist overseeing systematic reviews for guidelines and expert committee member. He is a contributing author to the Africa chapter of the 6th Intergovernmental Panel on Climate Change report. His work on climate change has centred on assessing the impacts of climate change on maternal health and HIV, consolidating his experience in the disciplines of clinical medicine, biostatistics, epidemiology and public health. He is presently part of a group of staff and students promoting divestment from fossil fuels at Wits University.
David Stead is an Infectious diseases specialist Physician, who completed his undergraduate, and specialist training at Groote Schuur hospital in 2013.
He relocated with his family to East London in 2015 to start an Infectious diseases unit within the departments of Medicine at Frere and Cecilia Makiwane hospitals. He and colleagues pioneered a training and support program for rural district doctors through a Discovery foundation grant in 2019. His research interests are TB diagnostics, novel HIV testing strategies, and SARS-CoV-2 transmission among Health care workers.
Ahmed Cordie is a consultant physician and research fellow at the department of Endemic Medicine, Cairo University Hospitals, the Founder of Kasr Al-Aini HIV and Viral Hepatitis Fighting Group and coordinator of Supreme Council of University Hospitals (SCU) Committee for Medical Virology and Blood-borne Pathogens. He is also the immediate past Chief of the HCV/HIV Co-infection Program at the National Committee for Combating Viral Hepatitis (NCCVH).
Dr Cordie’s areas of expertise include Viral hepatitis and HIV /viral hepatitis co-infection. After the implementation of the 1st collaboration protocol between Cairo University Hospitals and Fever Hospitals in Cairo in 2015, he was capable of grasping the attention of the health care providers especially whom working at the university hospitals towards the people living with HIV (PLHIV). This was achieved by launching the first specialty clinics that was designed to serve and treat co-infections (Viral hepatitis/HIV, TB-HIV) and co-morbidities such as: Dyslipidemia, NAFLD /NASH, Cardiovascular and Bone disorders.
Anastacia Tomson is a medical doctor, author, and activist, who has clinical experience in treating trans patients, and in educating medical students on issues relating to healthcare for trans and other LGBTQIA+ patients. Anastacia herself identifies as trans and uses her lived experience as well as her scientific background to inform her work in promoting access to gender affirming care.
Anna Coutsoudis is Professor Emeritus in the School of Clinical Medicine, University of KwaZulu Natal, Durban. She had a 30-year career as a medical scientist in the Department of Paediatrics & Child Health, University KwaZulu-Natal. Her original research work on HIV and breastfeeding played an important role in the shaping of the WHO guidelines on HIV and Infant Feeding. Twenty years ago she set up an NGO to provide care for AIDS orphans and HIV prevention programmes in primary schools. In order to provide optimum care of the orphans she also established the first community-based breastmilk bank in South Africa. In 2009 she was a recipient of the Science for Society Gold Medal award from the Academy of Science of South Africa.
Over the last five years she has been collaborating with the Department of Health, KZN, to scale up human milk banking in KZN and has been leading research into low cost accessible technology for pasteurization of donor human milk. She is passionate about appropriate and respectful primary health care especially for disempowered mothers and children, which led her into the field of interrogating and updating health policies with the latest available scientific research, including the CTX prophylaxis policy for HIV exposed children.
Indira Govender MBChB MMed FCPHM PGDip Obstet is a medical doctor and specialist in public health medicine and is employed by the London School of Hygiene & Tropical Medicine. In 2014, Dr Govender worked for MSF in South Sudan, and in Sierra Leone as part of the Ebola outbreak response. She is based at the Africa Health Research Institute in Somkhele, KZN, where her population-based research interests are TB infection prevention and control, and transmission. Dr Govender has been a key member of the Stop Stockouts Project since its inception in 2013.
Jeannette Wessels holds a medical degree from Stellenbosch University, a master’s degree in public health (University of Roehampton, London) and a Diploma in HIV Management (CMSA). She has more than 18 years of experience in capacity building and training, program planning, project implementation, monitoring, and quality improvement in the fields of adult and pediatric ART, PMTCT, and TB/HIV integration. Since 2015, she has also worked closely with maternal, neonatal and child health (MNCH) programmes. Her special interests are Implementation Science, Continuous Quality Improvement, and Health Systems Strengthening within the fields of HIV, PMTCT and maternal and child health.
Moherndran Archary is a Paediatric Infectious Disease Specialist in the Department of Paediatrics and Child Health at King Edward VIII Hospital affiliated to the Nelson R Mandela School of Medicine, University of KwaZulu-Natal.
He is actively involved with the management of children with HIV. His research interests include antiretroviral drug therapeutics, viral resistance and optimal timing of initiation of antiretroviral therapy in the developing world. He is the current chair of the SAHCS Child and Adolescent Committee
Richard Kaplan is a Senior Researcher and the Key Populations Divisional Lead at the Desmond Tutu HIV Foundation (DTHF) at the University of Cape Town. He is a medical doctor with an interest in HIV and TB research and has been working on HIV treatment and prevention trials at the DTHF Clinical Trials Unit in Groote Schuur Hospital since 2003. The main focus of his work has been on developing and managing clinical trials on novel HIV treatments and strategies. He is currently the DTHF principal investigator on the University of New South Wales D2EFT study looking at strategies for second line HIV treatment as well as a number of pharmaceutical studies examining the efficacy of dolutegravir in both first- and second-line ART. As Key Populations Divisional Lead, he oversees HIV prevention trials for men who have sex with men and transgender people.
Helena Rabie is a specialist in the field of paediatric infectious diseases and an associate professor of paediatrics at Tygerberg Hospital and University of Stellenbosch. She has extensive experience in managing HIV-infected children and children with tuberculosis and has been part of several research protocols on best practice treatment strategies.
Trudie Retief is the Manager of the Publishing Division at AOSIS (Pty) Ltd, which is the publishing house for the Southern African Journal of HIV Medicine. Trudie’s role has been focusing on continued innovation, quality systems and practices, international publishing standards and improved technologies, and she has been actively involved in open access scholarly publishing over the past 14 years. Trudie has a design and engineering background.
Ute Feucht (MBChB, FCPaed(SA), MMed(Paed), Dip HIV Man(SA), CAHM, PhD) works as a Paediatrician in the Tshwane District Clinical Specialist Team in the Gauteng Province. She has a joint appointment with the Department of Paediatrics of the University of Pretoria, and is also the Director of the Research Centre for Maternal, Fetal, Newborn and Child Health Care Strategies of the University of Pretoria.
Annemarie M.J. Wensing, MD, PhD is a Clinical Virologist at the University Medical Center Utrecht and a Honorary Professor at the University of the Witwatersrand in Johannesburg. She attained her MD at the University of Utrecht. During her post graduate rotations she became involved in clinical HIV research and care. She worked at the HIV-outpatient clinic of the University Medical Center (UMC) Utrecht and was subsequently trained as a clinical virologist. She obtained her PhD on Transmission of drug resistant HIV-1. As consultant she advises infectious disease specialists from multiple HIV-centers in the Netherlands.
Her research focuses on HIV reservoirs and on transmission and mechanisms of HIV drug-resistance. She is a principal investigator of several projects about HIV drug resistance and laboratory monitoring and co PI of the IciStem program that guides and investigate a potential HIV cure by stem cell transplantation. She served as a governing board member of EACS and is co-chair of their upcoming conference, a founding member of the European Society of Antiviral Resistance and coordinator of the SPREAD Program focusing on transmission of HIV-drug resistance, a member of the WHO HIV Drug Resistance ResNet and chair of the IAS-USA HIV-1 mutations panel.
Dr Camilla Wattrus is currently employed by SAHCS as the Clinical Content Manager. As part of her role, she manages the SAJHIVMED and SAHCS online courses. Prior to joining SAHCS in March 2021, Camilla worked in the field of medical knowledge translation and guideline development for many years. She is a medical doctor, has the Diploma in HIV Management and clinical experience in a range of areas, including primary care and family medicine, HIV research and paediatrics.
Anil Padavatan is a health and human rights activist, who has worked for many years in the fields of HIV, human rights and access to health care. He holds an Honours Degree in Psychology from Rhodes University, and has worked for various human rights organisations, including the AIDS Law Project and the SA HIV Clinicians Society. Anil joined Gender Dynamix (GDX) as Health Advocacy Officer in 2020 and is currently Co-Programmes Manager at GDX. As a transgender man, Anil brings both a professional and personal perspective to his work, and his particular area of interest is the realization of socio-economic rights, especially the right to access to health care.
Elliott Kotze is a counselling psychologist and researcher with extensive experience in gender-affirming healthcare. His work broadly focuses on improving the quality of life of queer and gender diverse folks through the strategic implementation of community-driven interventions.
Dr Zamasomi Luvuno’s research interest is advocacy for trans communities. Her PhD work focused on trans people’s sexual and reproductive needs and the experiences of seeking care in the public health facilities in an HIV hyper-endemic setting in KwaZulu-Natal, South Africa. Zama is a nurse by background profession and currently works as an implementation science researcher, thus her interest is to see trans health, integrated into the DOH package of health care services. This is why she is “delighted to be part of this process of development of professional resources, such as the guidelines”.
Dr Kevin Adams is a plastic and reconstructive surgeon with considerable experience in gender affirming surgery. He completed his specialist training at UCT where he has remained and now is a Senior Specialist and lecturer. Dr Adams has a key interest in gender affirming surgery. He is a member of the Transgender Clinic Team at Groote Schuur Hospital, Cape Town.
Chris/tine McLachlan is a clinical psychologist with a special interest in the field of Gender Affirming Healthcare. Chris is the co-chair of the SAHCS South African Gender Affirming Healthcare Guidelines development team, chairperson of the Professional Association for Transgender Health South Africa (PATHSA), vice-chair of the Psychological Society of South Africa’s Sexuality and Gender Division, member of the Wits RHI advisory board, and works at the Thuthuzela Care Centre, Department of Health, KwaZulu-Natal. Chris published various academic articles and opinion pieces, trained and lectured in the field of trans and gender diversity and was the runner-up for the WPATH student award in 2018. Chris is passionate about a participatory approach to gender affirming healthcare.
Elma de Vries is a family physician who works at Heideveld Community Day Centre in Cape Town, South Africa, a senior lecturer in the School of Public Health and Family Medicine at the University of Cape Town and a member of the Transgender Clinic Team at Groote Schuur Hospital, Cape Town. Elma is a founding member and current secretary of the Professional Association for Transgender Health South Africa (PATHSA).